In SHH pathway, the deregulation of SMO-SHH signaling pathway can cause neurodegenerative diseases such as PD, and the activation of the SMO-SHH-GLI pathway has neuroprotective, anti-inflammatory and antioxidant properties. This evidence concerns the gene GLI1 and neurodegenerative disease.